DISEASE BURDEN IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS

被引：0
|
作者：
Silvestri, Nicholas
Ait-Tihyaty, Maria
Gandhi, Kavita
Turkoz, Ibrahim
Daskiran, Mehmet
Shaddinger, Bonnie C.
Lindenstrom, Ewa
机构：
来源：
MUSCLE & NERVE | 2024年 / 70卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
MG40
引用
收藏
页码：652 / 653
页数：2
相关论文
共 50 条
  • [31] Efgartigimod demonstrates consistent improvements in patients with generalized myasthenia gravis of shorter disease duration
    Genge, Angela
    Bril, Vera
    Vu, Tuan
    Brauer, Edward
    Kerstens, Rene
    Howard, James F., Jr.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [32] Efgartigimod Demonstrates Consistent Improvements in Generalized Myasthenia Gravis Patients of Shorter Disease Duration
    Bril, Vera
    Vu, Tuan
    Brauer, Edward
    Kerstens, Rene
    Howard, James
    NEUROLOGY, 2023, 100 (17)
  • [33] Understanding the burden of refractory myasthenia gravis
    Schneider-Gold, Christiane
    Hagenacker, Tim
    Melzer, Nico
    Ruck, Tobias
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2019, 12
  • [34] Correction to: Burden of disease in myasthenia gravis: taking the patient’s perspective
    Sophie Lehnerer
    Jonas Jacobi
    Ralph Schilling
    Ulrike Grittner
    Derin Marbin
    Lea Gerischer
    Frauke Stascheit
    Maike Krause
    Sarah Hoffmann
    Andreas Meisel
    Journal of Neurology, 2022, 269 : 5688 - 5689
  • [35] THE HUMANISTIC AND ECONOMIC BURDEN OF MYASTHENIA GRAVIS (MG) - A DEBILITATING & COSTLY DISEASE
    Tomaras, D.
    Marshall, S.
    Forsythe, A.
    VALUE IN HEALTH, 2020, 23 : S279 - S279
  • [36] Suitable indications of eculizumab for patients with refractory generalized myasthenia gravis
    Oyama, Munenori
    Okada, Kensuke
    Masuda, Masayuki
    Shimizu, Yuko
    Yokoyama, Kazumasa
    Uzawa, Akiyuki
    Kawaguchi, Naoki
    Ikeguchi, Ryotaro
    Hoshino, Yasunobu
    Hatano, Taku
    Ozawa, Yukiko
    Nakahara, Jin
    Aizawa, Hitoshi
    Kitagawa, Kazuo
    Hattori, Nobutaka
    Kuwabara, Satoshi
    Murai, Hiroyuki
    Suzuki, Shigeaki
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2020, 13
  • [37] Respiratory function and control of breathing in patients with generalized Myasthenia Gravis
    Kalopissi, KG
    Evangelopoulou, V
    Katsis, A
    Frangoulidou, E
    Konstantinidis, A
    Mandragos, K
    INTENSIVE CARE MEDICINE, 2001, 27 : S267 - S267
  • [38] A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis
    Pasnoor, Mamatha
    He, Jianghua
    Herbelin, Laura
    Burns, Ted M.
    Nations, Sharon
    Bril, Vera
    Wang, Annabel K.
    Elsheikh, Bakri H.
    Kissel, John T.
    Saperstein, David
    Shaibani, J. Aziz
    Jackson, Carlayne
    Swenson, Andrea
    Howard, James F., Jr.
    Goyal, Namita
    David, William
    Wicklund, Matthew
    Pulley, Michael
    Becker, Mara
    Mozaffar, Tahseen
    Benatar, Michael
    Pazcuzzi, Robert
    Simpson, Ericka
    Rosenfeld, Jeffrey
    Dimachkie, Mazen M.
    Statland, Jeffrey M.
    Barohn, Richard J.
    NEUROLOGY, 2016, 87 (01) : 57 - 64
  • [39] SAFETY AND EFFICACY OF SUBCUTANEOUS IMMUNOGLOBULIN IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS
    Katzberg, Hans
    Idiaquez, Juan
    Mendoza, Meg
    Barnett, Carolina
    Huszti, Ella
    Lovblom, Erik
    Wang, Stella
    Bril, Vera
    MUSCLE & NERVE, 2024, 70 (03) : 683 - 683
  • [40] Efficacy and safety of tocilizumab in patients with refractory generalized myasthenia gravis
    Ruan, Zhe
    Tang, Yonglan
    Gao, Ting
    Li, Chunhong
    Guo, Rongjing
    Sun, Chao
    Huang, Xiaoxi
    Li, Zhuyi
    Chang, Ting
    CNS NEUROSCIENCE & THERAPEUTICS, 2024, 30 (06)
12345